Global Injectable Drug Delivery Devices Markets Report 2022 Featuring Major Players – Becton, Dickinson and Co, Gerresheimer, Eli Lilly and Co, Pfizer, & Teva Pharmaceutical Industries – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Injectable Drug Delivery Devices Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.

Injectable Drug Delivery Devices Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global injectable drug delivery devices market.

This report focuses on the injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the injectable drug delivery devices market which will be shaping and changing our lives over the next ten years and beyond, including the market’s response to the challenge of the global pandemic.

Where is the largest and fastest growing market for the injectable drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Injectable Drug Delivery Devices market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider injectable drug delivery devices market, and compares it with other markets.

The countries included in the injectable drug delivery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

Report Scope

• The market characteristics section of the report defines and explains the market
• The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery
• Market segmentations break down market into sub markets
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified
• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this
• The injectable drug delivery devices market section of the report gives context. It compares the injectable drug delivery devices market with other segments of the injectable drug delivery devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, injectable drug delivery devices indicators comparison

Markets Covered:

• By Type: Conventional Injectable; Pre-filled Syringes; Auto-injectors; Pen-injectors
• By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
• By End User: Hospitals And Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories; Other End Users

Major Companies

• Becton, Dickinson and Company
• Gerresheimer AG
• Eli Lilly and Company
• Pfizer inc.
• Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1. Executive Summary

2. Injectable Drug Delivery Devices Market Characteristics

3. Injectable Drug Delivery Devices Market Trends And Strategies

4. Impact Of COVID-19 On Injectable Drug Delivery Devices

5. Injectable Drug Delivery Devices Market Size And Growth

5.1. Global Injectable Drug Delivery Devices Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Injectable Drug Delivery Devices Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Injectable Drug Delivery Devices Market Segmentation

6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Conventional Injectable
• Pre-filled Syringes
• Auto-injectors
• Pen-injectors

6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Autoimmune Diseases
• Hormonal Disorders
• Oncology
• Orphan Diseases
• Pain Management
• Respiratory Therapy
• Other Applications

6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Hospitals And Clinics
• Home Healthcare Settings
• Pharmaceutical And Biotechnological Companies
• Research Laboratories
• Other End Users

7. Injectable Drug Delivery Devices Market Regional And Country Analysis

7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

• Becton, Dickinson and Company
• Gerresheimer AG
• Eli Lilly and Company
• Pfizer inc.
• Teva Pharmaceutical Industries ltd.
• Schott AG
• Baxter International
• Owen Mumford
• Mylan N.V.
• Sanofi
• Antares Pharma
• Bespak
• Ypsomed
• Unilife Corporation
• Genentech Inc.
• Alkermes Plc.

For more information about this report visit https://www.researchandmarkets.com/r/gje60q

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900